PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsTranexamic acid
Tranexamic acid
Cyklokapron, Lysteda, Tranexamic Acid (tranexamic acid) is a small molecule pharmaceutical. Tranexamic acid was first approved as Cyklokapron on 1986-12-30. It is used to treat inherited blood coagulation disorders and subarachnoid hemorrhage in the USA. The pharmaceutical is active against plasminogen.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
nervous system diseasesD009422
cardiovascular diseasesD002318
hemic and lymphatic diseasesD006425
hereditary congenital and neonatal diseases and abnormalitiesD009358
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Cyklokapron, Lysteda, Tranexamic acid (discontinued: Cyklokapron, Tranexamic acid)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Tranexamic acid
Tradename
Company
Number
Date
Products
LYSTEDAAmring PharmaceuticalsN-022430 RX2009-11-13
1 products, RLD, RS
TRANEXAMIC ACIDExela Pharma SciencesN-212020 RX2019-04-15
1 products, RLD, RS
CYKLOKAPRONPfizerN-019281 RX1986-12-30
1 products, RLD, RS
Show 1 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
cyklokapronNew Drug Application2025-01-30
pure whitenol serumunapproved drug other2015-03-06
rosacea therapyC2002632023-12-29
skinmd laboratories pure whitenol intensiveunapproved drug other2019-12-24
skinmd laboratories pure whitenol serumunapproved drug other2019-12-24
skinmd laboratories revitox blueunapproved drug other2018-11-28
tranexamic acidANDA2025-03-01
tranexamic acid in sodium chlorideANDA2025-01-14
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
subarachnoid hemorrhageEFO_0000713D013345I60
inherited blood coagulation disorders—D025861—
Agency Specific
FDA
EMA
Expiration
Code
TRANEXAMIC ACID, TRANEXAMIC ACID, AMNEAL
2024-04-16CGT
Patent Expiration
Patent
Expires
Flag
FDA Information
Tranexamic Acid, Lysteda, Amring Pharms
79477392025-03-04DP
80221062025-03-04U-1182
82737952025-03-04U-1182
84870052025-03-04DPU-1182
87911602025-03-04DPU-1182
88093942025-03-04DPU-1182
89571132025-03-04DPU-1182
90609392025-03-04DP
ATC Codes
B: Blood and blood forming organ drugs
— B02: Antihemorrhagics
— B02A: Antifibrinolytics
— B02AA: Antifibrinolytic amino acids
— B02AA02: Tranexamic acid
HCPCS
No data
Clinical
Clinical Trials
885 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Spinal fusionD013123————1——1
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTranexamic acid
INNtranexamic acid
Description
Tranexamic acid is a monocarboxylic acid. It has a role as an antifibrinolytic drug and a hematologic agent. It is functionally related to a cyclohexanecarboxylic acid.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
NC[C@H]1CC[C@H](C(=O)O)CC1
Identifiers
PDB—
CAS-ID1197-18-8
RxCUI—
ChEMBL IDCHEMBL877
ChEBI ID48669
PubChem CID5526
DrugBankDB00302
UNII ID6T84R30KC1 (ChemIDplus, GSRS)
Target
Agency Approved
PLG
PLG
Organism
Homo sapiens
Gene name
PLG
Gene synonyms
NCBI Gene ID
5340
Protein name
plasminogen
Protein synonyms
plasmin
Uniprot ID
Q6PA00
Mouse ortholog
Plg (18815)
plasminogen (Q91WJ5)
Alternate
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Tranexamic acid
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 16,397 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
3,786 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use